Digital Sustainability
Smart technologies driving the green transition in pharma
Pharma’s Dilemma: Innovation vs. Environmental Impact
The pharmaceutical industry is finding itself in an increasingly tight corner. While its aim to develop effective medicines remains a driving force, the industry is under growing pressure to address its significant environmental footprint.
From energy-intensive production processes to the generation of hazardous waste, traditional pharmaceutical manufacturing models come with major environmental costs, and pharmaceutical companies are being urged to respond to these issues.
More than just a noble aim, transitioning to sustainable practices is now an operational necessity for pharmaceutical firms. While a green transition may seem daunting to initiate, it’s a process that offers profound opportunities for operational cost reductions.
Download the white paper, to examine the key production issues in the pharmaceutical industry, the sustainable solutions that companies can pursue, and how Masco Group Automation (MGA) can provide an effective technological way forward.